Thomas P. Mathers

This profile gathers the share dealings of Thomas P. Mathers in CoLucid Pharmaceuticals, Inc. We count 30 filings; the first trade dates from 4 March 2016 and the latest from 1 March 2017.

The open-market record consists of 17 sales worth €477k, with no purchase. Besides market trades, the filings include 2 share grants and 9 option exercises. 2017 to date brings no purchases and 3 sales.

Most recently, on 1 March 2017, the filings show a transaction worth €7.6M in CoLucid Pharmaceuticals, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.